ライフサイエンスコーパス: biopsy specimen

1 D within the first 3 postoperative years (57 biopsy specimens).

2 histopathologic examination of the excision biopsy specimen.

3 o had segmental glomerular deposits on renal biopsy specimen.

4 main histologic features of renal allograft biopsy specimens.

5 with known cagA status and in human gastric biopsy specimens.

6 sults in an independent set of 74 unselected biopsy specimens.

7 ained in the same region of the liver as the biopsy specimens.

8 kidney grafts or podocytes of native kidney biopsy specimens.

9 fibrosis and inflammation in renal allograft biopsy specimens.

10 ic parameters determined by analysis of bone biopsy specimens.

11 ession in hepatocytes and HCV-infected liver biopsy specimens.

12 ol content were measured in vastus lateralis biopsy specimens.

13 ophic or myopathic changes present in muscle biopsy specimens.

14 nal transplant have been defined in clinical biopsy specimens.

15 s, given the availability of allergic tissue biopsy specimens.

16 nal cord, human postmortem brain, and glioma biopsy specimens.

17 LBCL and are applicable to paraffin-embedded biopsy specimens.

18 d major basic protein were done on bronchial biopsy specimens.

19 ishing benign from malignant tissue in liver biopsy specimens.

20 d by histopathologic examination of duodenal biopsy specimens.

21 analysis of the 16 DNA adducts in human lung biopsy specimens.

22 ately 4.5-fold in H. pylori-infected gastric biopsy specimens.

23 metabolism were measured in skeletal muscle biopsy specimens.

24 erexpressed in sporadic CIPO in sera and gut biopsy specimens.

25 c tissue specimens, blood cultures, or other biopsy specimens.

26 Ls) from RCDII as well as non-RCDII duodenal biopsy specimens.

27 ocked STa-provoked anion secretion in rectal biopsy specimens.

28 PM8); and nerve growth factor (NGF) in nasal biopsy specimens.

29 iomarker for rapid diagnosis of FGN in renal biopsy specimens.

30 r rejection phenotypes in 24-month follow-up biopsy specimens.

31 terations were detected in 44% (11 of 25) of biopsy specimens.

32 in H. pylori-infected and uninfected gastric biopsy specimens.

33 essed in human chronic allograft nephropathy biopsy specimens.

34 re can easily be recognized in routine renal biopsy specimens.

35 ction status ascertained by histology in 107 biopsy specimens.

36 ional methods, we diagnosed rejection in 205 biopsy specimens (28%): 67 pure TCMR, 110 pure ABMR, and

37 g microarrays, we diagnosed rejection in 228 biopsy specimens (32%): 76 pure TCMR, 124 pure ABMR, and

38 ble nitric oxide synthase (P = 0.02) in skin biopsy specimens 48 hours after experimental sunburn.

39 lammation classification, with >90% of renal biopsy specimens adequately classified by FTIR imaging.

40 els were measured in human and rodent muscle biopsy specimens after 1 bout of exercise.

41 Histologic analysis of liver biopsy specimens allows for grading and staging of nonal

42 Renal biopsy specimen analysis revealed amyloidosis with exten

43 sibility of organoid culture from metastatic biopsy specimens and (ii) to compare the genetic diversi

44 Histopathological studies of patient biopsy specimens and animal models have revealed that ch

45 Control nasal biopsy specimens and blood were obtained from healthy vo

46 methods for cccDNA quantification from liver biopsy specimens and cell lines expressing the virus are

47 he proteomic content of glomeruli in patient biopsy specimens and detected DnaJ heat shock protein fa

48 A whole-transcriptome analysis of heart biopsy specimens and formalin-fixed, paraffin-embedded s

49 l mucosa-associated lymphoid tissue (RAMALT) biopsy specimens and nasal brush samples collected antem

50 l mucosa-associated lymphoid tissue (RAMALT) biopsy specimens and nasal brushings collected antemorte

51 ive assay for detection of PrP(CWD)in rectal biopsy specimens and other antemortem samples and, with

52 We used esophageal biopsy specimens and plasma samples from control subject

53 second protein boost, we obtained lymph node biopsy specimens and quantified the frequency of total a

54 ere compared to histopathology findings from biopsy specimens and radiology reports on MR images to e

55 idated a classification model using 49 renal biopsy specimens and subsequently tested the robustness

56 ased IL-36alpha expression detected in renal biopsy specimens and urine samples from patients with re

57 of v-lesions to prognosis in 703 indication biopsy specimens and used microarray-based molecular tes

58 assay for detection of CWD prions in RAMALT biopsy specimens and, with further investigation, has po

59 LAD within 3 years after transplantation (48 biopsy specimens) and patients rapidly developing CLAD w

60 data, histologic characteristics (allograft biopsy specimen), and donor-specific anti-HLA antibodies

61 e included: 52 with autopsies, 22 with brain biopsy specimens, and 31 with pathologic samples from he

62 mRNA and protein levels in vitro, bronchial biopsy specimens, and mice.

63 the associations of TRIs in renal transplant biopsy specimens are not known.

64 Psoriatic skin biopsy specimens, as well as normal human skin, blood, a

65 that the presence of TRIs in renal allograft biopsy specimens associates with poor allograft outcomes

66 m routinely collected brain biopsy specimen, biopsy specimen at hematoma evacuation, or autopsy) and

67 esence of CAA from routinely collected brain biopsy specimen, biopsy specimen at hematoma evacuation,

68 9V DNA and messenger RNA from endomyocardial biopsy specimens, bone marrow specimens, and circulating

69 low cytometric analysis of cells from rectal biopsy specimens, bone marrow, and mesenteric lymph node

70 G in the tubular immune deposits on the ABBA biopsy specimen but not the control specimen analyzed.

71 9 are found in immune deposits of IMN kidney biopsy specimens, but the pathway of complement activati

72 tigations of whole lung samples and resected biopsy specimens by matrix-assisted laser desorption/ion

73 Encoded proteins were investigated in skin biopsy specimens by means of immunohistochemistry.

74 d renal pathologists, in 975 postreperfusion biopsy specimens collected from 2005 to 2009 after livin

75 ons by the TRPV1 agonist capsaicin in rectal biopsy specimens collected from 9 patients with IBS (ROM

76 amma isoforms was observed in HIV-related KS biopsy specimens compared with non-HIV-related KS and NS

77 NA expression levels were lower in HCC liver biopsy specimens compared with normal liver RNA.

78 Immunohistochemistry analyses of bronchial biopsy specimens confirmed increased levels of CCL26 in

79 tainings for calprotectin in renal allograft biopsy specimens confirmed the serological results.

80 on in the podocytes and glomeruli from human biopsy specimens correlated with glucocorticoid responsi

81 Finally, immunostaining in kidney biopsy specimens demonstrated overexpression of ShcA in

82 Muscle biopsy specimens demonstrated type I fiber atrophy and t

83 southern China and de novo assembled 18 NPC biopsy specimen-derived EBV (NPC-EBV) genomes, designate

84 After histologic analysis of the bone marrow biopsy specimen, diagnosis of Waldenstrom macroglobuline

85 Therefore, v-lesions in indication biopsy specimens do not affect prognosis and can reflect

86 ares the diagnostic performance in 6526 skin biopsy specimens examined from 2008 to 2010 with a stand

87 ares the diagnostic performance in 6526 skin biopsy specimens examined from 2008 to 2010 with a stand

88 th a standard method of processing with 8584 biopsy specimens examined in 2015 with EVD and DD.

89 th a standard method of processing with 8584 biopsy specimens examined in 2015 with EVD and DD.

90 Human colonic biopsy specimens exposed to G. duodenalis were depleted

91 proximal tubules from 98 human needle kidney biopsy specimens for microRNA expression analysis using

92 BMP6, compared with controls, was found in a biopsy specimen from 1 patient.

93 Collection of a single additional biopsy specimen from any D1 site increased the sensitivi

94 Collection of a single additional biopsy specimen from any site in the D1 intestine increa

95 munohistochemistry studies were performed on biopsy specimens from 10 patients with AD and 14 patient

96 Bronchial biopsy specimens from 12 control subjects, 24 patients w

97 tudies at baseline, 4 weeks, and 16 weeks in biopsy specimens from 15 patients with moderate-to-sever

98 and quantitative real-time PCR, we assessed biopsy specimens from 19 children with AD younger than 5

99 The biopsy specimens from 2008 to 2010 were processed in a h

100 Non-small-cell lung cancer biopsy specimens from 2011 to 2012 were collected retros

101 ital-based general pathology laboratory; the biopsy specimens from 2015 were processed in a private d

102 We analyzed biopsy specimens from 21 genotyped patients with ichthyo

103 The NanoString technology used in 38 cSCC biopsy specimens from 24 patients with cSCC (19 men and

104 and a ligand (PD-L2) was assessed in 38 cSCC biopsy specimens from 24 patients with cSCC.

105 Seven hundred thirty-eight biopsy specimens from 246 endoscopic procedures were eva

106 We collected blood and intestinal biopsy specimens from 268 patients at tertiary medical c

107 iopsy specimens from control patients, renal biopsy specimens from 44 patients with acute AAV had mor

108 on formalin-fixed, paraffin-embedded (FFPE) biopsy specimens from 48 cervical SCCs and 23 vulvar SCC

109 The authors prospectively obtained 232 biopsy specimens from 74 patients (177 ex vivo biopsy sa

110 A total of 221 biopsy specimens from 74 patients, including atrophic ga

111 expression of candidate immune genes in skin biopsy specimens from 85 individuals with leprosy.

112 Thus, we analyzed serial liver biopsy specimens from adult liver recipients enrolled in

113 e because of the difficulty of taking thymic biopsy specimens from affected children.

114 in 1-mm basal layers was determined in skin biopsy specimens from all lesions stained with hematoxyl

115 nohistological and RT-PCR analysis of muscle biopsy specimens from anti-MDA5 and classic DM were comp

116 Lung biopsy specimens from asthmatic and nonasthmatic patient

117 protein expression was assessed in bronchial biopsy specimens from asthmatic patients (n = 22) and he

118 Biopsy specimens from both periods were diagnosed by the

119 eling and TGF-beta1 expression in esophageal biopsy specimens from children (n = 32) with EoE treated

120 Here we report that, compared with biopsy specimens from control patients, renal biopsy spe

121 luating expression of esophageal proteins in biopsy specimens from control subjects and patients with

122 evels of moesin were also observed in muscle biopsy specimens from DMD, Ullrich CMD, and merosin-defi

123 racterize mucosal iNOS-producing leukocytes, biopsy specimens from H. pylori-infected patients, contr

124 To test this, we analyzed gastric biopsy specimens from H. pylori-positive and -negative p

125 Age-matched controls consisted of muscle biopsy specimens from healthy children aged 1 to 3 years

126 Biopsy specimens from healthy controls were obtained fro

127 Cutaneous wart biopsy specimens from HIV-positive patients harbored com

128 metatranscriptomic RNA sequencing of stomach biopsy specimens from individuals with different H. pylo

129 Among 50 subjects with biopsy specimens from infected and uninfected sites, cul

130 Biopsy specimens from inflamed colon of 8 patients with

131 ical value of a granzyme B imaging paradigm, biopsy specimens from melanoma patients on checkpoint in

132 Fifty-one hepatic biopsy specimens from OLT patients were collected under

133 mass spectrometry and analyzed BMP6 in liver biopsy specimens from patients by immunohistochemistry.

134 age FMF was made by a blinded review of skin biopsy specimens from patients presenting with plaques.

135 esistance was additionally observed in tumor biopsy specimens from patients treated with these drugs.

136 hanger 3 (NHE3) were measured in human ileal biopsy specimens from patients who did and did not recei

137 gnificantly increased in epithelial cells of biopsy specimens from patients with active EoE compared

138 In fresh colonic biopsy specimens from patients with active UC, the miR21

139 We collected duodenal biopsy specimens from patients with acute cholera after

140 In liver biopsy specimens from patients with acute hepatitis B, b

141 ns were differentially expressed in lesional biopsy specimens from patients with AE relative to norma

142 s, eosinophils have been detected in gastric biopsy specimens from patients with AIG.

143 , to reduce mucosal morphometric measures in biopsy specimens from patients with celiac disease.

144 looxygenase2 expression was higher in lesion biopsy specimens from patients with DCL than in those fr

145 ein S immunostaining was performed on kidney biopsy specimens from patients with diabetic nephropathy

146 Accordingly, biopsy specimens from patients with EoE evidenced a prof

147 gmental allergen challenge and in esophageal biopsy specimens from patients with eosinophilic esophag

148 in the TH1:TH2 ratio (0.16 and 0.07) within biopsy specimens from patients with erythrodermic psoria

149 sor, ATM, in gastric epithelial cells and in biopsy specimens from patients with GC.

150 This case-control study obtained punch biopsy specimens from patients with HS (lesional and non

151 Supernatants from rectal biopsy specimens from patients with IBS, but not from th

152 In this study, rectosigmoid mucosal biopsy specimens from patients with ICL and healthy cont

153 s with active EoE compared with that seen in biopsy specimens from patients with inactive EoE or cont

154 nd integrin-beta3 were highly colocalized in biopsy specimens from patients with inflammatory GN.

155 /PD-L1 and PDCD1LG2/PD-L2 alterations in 108 biopsy specimens from patients with newly diagnosed cHL

156 In salivary gland biopsy specimens from patients with pSS, we identified a

157 ls were also observed at increased levels in biopsy specimens from patients with severe asthma.

158 In studies of rectal biopsy specimens from patients, we found that HRH1-media

159 ased miR-21 was found in peritoneal membrane biopsy specimens from PD patients compared to healthy co

160 protein was decreased in peritoneal membrane biopsy specimens from PD patients compared to healthy co

161 NA levels were selectively increased in skin biopsy specimens from persons with recurrent HSV-2, whil

162 es of CD8(+) T cells in insulitic lesions in biopsy specimens from six subjects with recent-onset typ

163 best discriminated acute cellular rejection biopsy specimens from specimens without rejection.

164 s were found within the islets in pancreatic biopsy specimens from subjects without diabetes or from

165 In this study, we collected 18 NPC biopsy specimens from the Hunan Province in southern Chi

166 ession by immunofluorescence in podocytes of biopsy specimens from these or other kidney grafts or po

167 ling-associated genes in transbronchial lung biopsy specimens from two cohorts with 18 patients each:

168 From a cohort of 771 kidney biopsy specimens from two North American and five Europe

169 ng) was significantly higher than in control biopsy specimens from unaffected skin.

170 without worsening fibrosis; patients without biopsy specimens from week 52 (17 in the CBDR group and

171 Four hundred eighty-six biopsy specimens had adequate lamina propria for evaluat

172 All biopsy specimens had adequate yields for genomic analysi

173 Prion detection within large intestinal GALT biopsy specimens has been used to estimate human and ani

174 ere based on a consensus panel review of the biopsy specimen histology.

175 Western blotting) and in normal and AE skin biopsy specimens (immunofluorescence).

176 ated in human melanoma and pancreatic cancer biopsy specimens in correlation with mortalin upregulati

177 IL-1R family genes in bronchial brushings or biopsy specimens in patients with SA was observed.

178 ences from viruses isolated from primary NPC biopsy specimens in this region, revealing whole-genome

179 protein 47, for ABMR in 53 renal transplant biopsy specimens, including 20 ABMR specimens, 24 cell-m

180 ci scores by Banff, respectively) on 1-year biopsy specimens independently correlated with graft los

181 Histologic analysis of the allograft biopsy specimen is the standard method used to different

182 hows that FTIR-based analysis of renal graft biopsy specimens is a reproducible and reliable label-fr

183 presence of v-lesions) in kidney transplant biopsy specimens is believed to have major prognostic an

184 asthma, but its expression within bronchial biopsy specimens is unknown.

185 Compared with normal kidney biopsy specimens, kidney specimens from patients with es

186 tional specimens with late TCMR and protocol biopsy specimens matched for biopsy time.

187 composite signature, developed using solely biopsy specimen-matched urine samples, predicted future

188 he ratio of 3-sialyllactose to xanthosine in biopsy specimen-matched urine supernatants best discrimi

189 However, our data suggest that using these biopsy specimens may miss individuals in the early stage

190 One hundred sixty-one HRA biopsy specimens (mean [SEM], 1.77 [0.11] biopsy specime

191 ed the same pattern of tubular injury in all biopsy specimens: microvesicular tubular epithelial cyto

192 Skin biopsy specimens (n = 16), serum (n = 114), blister flui

193 Bronchial biopsy specimens (n = 300) were collected from 15 patien

194 itive and cyclin D1-positive cells in tissue biopsy specimens), no upper limit on the number of previ

195 Any remaining BCG was quantified in a skin biopsy specimen obtained 2 weeks after challenge and use

196 ABMR became common in biopsy specimens obtained >1 year post-transplant and co

197 In 108 biopsy specimens obtained 10.2-35 years post-transplant,

198 Skin biopsy specimens obtained at baseline and weeks 1, 2, 4,

199 Mucosal biopsy specimens obtained at different time points befor

200 Biopsy specimens obtained during treatment demonstrated

201 rgets ACC-beta, TBC1D1, and TBC1D4 in muscle biopsy specimens obtained from 13 overweight/obese patie

202 We analyzed 936 biopsy specimens obtained from 378 individuals.

203 ic up-regulation was particularly evident in biopsy specimens obtained from calcineurin inhibitor-tre

204 ctivation in situ in sequential genital skin biopsy specimens obtained from HSV-2-seropositive subjec

205 profile genome-wide gene expression of skin biopsy specimens obtained from patients with GPP, PPP, o

206 e variation in EBV isolated from primary NPC biopsy specimens obtained from the Hunan Province.

207 Autoradiography of biopsy specimens obtained using 5 types of needles was p

208 Performing QABS on core-biopsy specimens obtained using PET/CT guidance enables

209 ves were used to quantify the activity along biopsy specimens obtained with these 2 needles and to ca

210 An Exophiala isolate was cultured from a biopsy specimen of a lesion on the forearm of a patient

211 , we obtained and analyzed the sections of a biopsy specimen of the cortex to determine the density o

212 Biopsy specimens of 11 HIV-related, 7 non-HIV-related Ka

213 18 biopsy specimens of immune-complex GN, 30 biopsy specimens of C3 GN, and 13 biopsy specimens of po

214 duced by lymphocytes recovered from duodenal biopsy specimens of cholera patients.

215 isplayed a significant increase in the liver biopsy specimens of chronically HCV-infected patients.

216 In duodenal biopsy specimens of healthy control subjects, CD4(+) T c

217 e determined the H. ducreyi transcriptome in biopsy specimens of human lesions and compared it to the

218 We studied glomerular C4d staining in 18 biopsy specimens of immune-complex GN, 30 biopsy specime

219 er 1 (GLI1) gene (HH-pathway target gene) in biopsy specimens of normal skin or BCC before and after

220 RNA-122 (miR-122) is down-regulated in liver biopsy specimens of patients with ALF and in acetaminoph

221 Intestinal biopsy specimens of patients with CD were scored accordi

222 By analyzing kidney biopsy specimens of patients with extracapillary GN, div

223 l cell suspensions and ILC3s sorted from gut biopsy specimens of patients with IBD were also analyzed

224 ssue from a rat model of NAFLD, and in liver biopsy specimens of patients with simple steatosis and n

225 lex GN, 30 biopsy specimens of C3 GN, and 13 biopsy specimens of postinfectious GN.

226 T cells cultured from biopsy specimens of subjects undergoing intradermal immu

227 Gastrointestinal and lung biopsy specimens of subjects with inflammatory disease w

228 endpoint was genome-wide gene expression in biopsy specimens of the rectosigmoid colonic mucosa.

229 oing biopsy was final pathologic analysis of biopsy specimens or follow-up imaging.

230 n detection of Marsh 2 or greater lesions in biopsy specimens or persistent high levels of tTGA.

231 ow-up review and ancillary investigations of biopsy specimens or serum samples.

232 associated with lower fibrosis in the first biopsy specimen (P < .001) and with the occurrence of at

233 RA biopsy specimens (mean [SEM], 1.77 [0.11] biopsy specimens per patient) were obtained from 91 pati

234 er in vitro cultures of ChHV5-positive tumor biopsy specimens (plugs) or organotypic cultures (rafts)

235 DGFRalpha expression in pre-operative needle biopsy specimens predicted poor overall survival during

236 fic CD4(+) T cells isolated from CD duodenal biopsy specimens produce cytokines able to trigger proli

237 udy, we recruited 12 patients diagnosed with biopsy specimen-proven EF between 2006 and 2009 from the

238 a method for quantitative autoradiography of biopsy specimens (QABS), to use this method to correlate

239 The histopathological examinationof the biopsy specimen revealed a lesion composed of malignant

240 The biopsy specimen revealed adenocarcinoma with no actionab

241 Examination of the renal biopsy specimen revealed amyloidosis with predominant in

242 Analysis of human liver biopsy specimens revealed a correlation of DPP4 expressi

243 Skin biopsy specimens revealed extensive hemorrhage and a pan

244 ed an accurate pathologic diagnosis, and one biopsy specimen showed benign liver parenchyma; both abl

245 Muscle biopsy specimens showed markedly thickened endothelium a

246 The dd-cfDNA level discriminated between biopsy specimens showing any rejection (T cell-mediated

247 er analysis on chronic allograft nephropathy biopsy specimens suggested that SNAI1 cytoplasmic up-reg

248 A lymphocytic infiltrate was seen on liver biopsy specimens taken from 2 subjects with transaminiti

249 istology and transcriptomic analyses on skin biopsy specimens taken from the challenge site in young

250 Brain biopsy specimens that exhibit encephalitis without speci

251 tatus of 74 genes in 151 follicular lymphoma biopsy specimens that were obtained from patients within

252 Here, we demonstrate, using patient biopsy specimens, that HD5 is also expressed as an activ

253 In the independent set of 74 renal graft biopsy specimens, the EndMT markers for the diagnosis of

254 ), instead of collecting and analyzing liver biopsy specimens to detect steatosis.

255 Renal biopsy specimens uniformly showed FSGS.

256 pathogens from infected and uninfected skin biopsy specimens using current molecular techniques.

257 Receptor expression is routinely measured in biopsy specimens using immunohistochemistry, although su

258 li from formalin-fixed and paraffin-embedded biopsy specimens using laser capture microdissection and

259 gene expression profiling of formalin-fixed biopsy specimens, using GeneChipp U133 Plus 2 microarray

260 Liver biopsy specimens, usually collected via the transjugular

261 midazole acetaldehyde, and supernatants from biopsy specimens was assessed by calcium imaging of mous

262 17C expression in H. pylori-infected gastric biopsy specimens was predominantly localized to epitheli

263 Studying the patient's renal biopsy specimen, we ascertained that obstructive tubular

264 hese subjects, matched labial salivary gland biopsy specimens were also analyzed by mass cytometry an

265 Biopsy specimens were analyzed according to standard met

266 Biopsy specimens were analyzed at the Department of Micr

267 Liver biopsy specimens were analyzed by in situ hybridization.

268 h edition] criteria) were preregistered, and biopsy specimens were analyzed for COX-2 by IHC.

269 Skin biopsy specimens were collected after intradermal allerg

270 Random biopsy specimens were collected and visible lesions were

271 Quadrantic D1 biopsy specimens were collected from 171 consecutive pat

272 Clinical data and gastric biopsy specimens were collected from 9 consecutive patie

273 Peripheral blood and skin biopsy specimens were collected from control subjects an

274 dom from 2008 through 2014; routine duodenal biopsy specimens were collected from D1 and the second p

275 Rectal biopsy specimens were collected, barostat studies were p

276 esults were available for 27 patients and 24 biopsy specimens were evaluated by histopathology, immun

277 Biopsy specimens were examined for psoriatic epidermal f

278 A total of 15110 skin biopsy specimens were included.

279 SAT biopsy specimens were obtained before and after the inte

280 Biopsy specimens were obtained for independent histologi

281 In patients with HS, biopsy specimens were obtained from lesional skin (axill

282 Small biopsy specimens were obtained from lesions and examined

283 derwent standard colonoscopies, during which biopsy specimens were obtained from the ileum.

284 Muscle biopsy specimens were obtained from the vastus lateralis

285 nt a mandatory baseline biopsy, and optional biopsy specimens were obtained on treatment and at disea

286 Bronchial biopsy specimens were processed for immunohistochemistry

287 records from 2010 to 2015 and available skin biopsy specimens were retrospectively reviewed.

288 Biopsy specimens were reviewed in a blinded manner by a

289 Biopsy specimens were reviewed in a blinded manner by a

290 Peptides extracted from biopsy specimens were sequenced and quantified using lab

291 The biopsy specimens were stained with hematoxylin-eosin and

292 Consecutive biopsy specimens were taken for whole-genome expression

293 Biopsy specimens were taken from nonlesional (baseline)

294 Skin biopsy specimens were taken from the infected site and a

295 Adipose tissue biopsy specimens were taken in a subsample of 853 men.

296 Endoscopic duodenal biopsy specimens were then collected and frozen until an

297 of surgical (n = 23) and endoscopic (n = 32) biopsy specimens were used as the reference standard; th

298 Treatment of human colonic biopsy specimens with 8Br-cGMP also activated catalase a

299 otyped the inflammatory infiltrates in renal biopsy specimens with BK polyomavirus-associated nephrop

300 We performed a meta-analysis in human kidney biopsy specimens with CAI, incorporating data available